Goal: Support comprehensive tissue healing through synergistic peptide mechanismscollagen synthesis (GHK-Cu), cell migration and angiogenesis (TB-500), and localized repair with anti-inflammatory effects (BPC-157) [1] [4] [5]
The findings suggest that thymosin beta 4 may potentially support the expression of microRNA 146a, a regulatory microRNA associated with the modulation of inflammatory signaling cascades
Peptides in this category act on these different stages: BPC-157 stimulates angiogenesis and tendon healing, TB-500 (Thymosin Beta-4) regulates actin and reduces fibrosis, ARA-290 targets neuroprotection via the EPO-R/CD131 receptor, and VIP modulates inflammation via the VPAC1/VPAC2 receptors
This peptide has been injected into thousands of people, sold by hundreds of clinics, discussed in millions of social media postsand the entire evidence base for its healing properties comes from rodents
M.PattB
Daily Dedication: Achieve optimal results with consistent use